Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL1749579

COC(=O)c1nc2n(c(=O)c1O)CCCC2N(C)[C@H](C)c1ccccc1.O=C(O)C(F)(F)F

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.43
CYP2C9 P11712 1/20 0.41
DPP4 P27487 5/20 0.35
DPP7 Q9UHL4 5/20 0.35
ERCC1 P07992 1/20 0.33
FEN1 P39748 1/20 0.33
ERCC4 Q92889 1/20 0.33
PDE9A O76083 2/20 0.32
LOXL2 Q9Y4K0 1/20 0.32
AADAT Q8N5Z0 1/20 0.32
DPP8 Q6V1X1 1/20 0.32
RNASEH1 O60930 1/20 0.32
CCR5 P51681 2/20 0.31
CHRM2 P08172 1/20 0.31
CHRM4 P08173 1/20 0.31
CHRM5 P08912 1/20 0.31
CHRM1 P11229 1/20 0.31
CHRM3 P20309 1/20 0.31
GPR6 P46095 1/20 0.31
HRH4 Q9H3N8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL1751641 1.00 KCNH2 (0.43) KCNH2CYP2C9DPP4DPP7ERCC1
Hydrochloric Acid SCHEMBL1751097 0.78 KCNH2 (0.47) KCNH2CYP2C9ERCC1FEN1ERCC4
SCHEMBL1749201 0.77 CYP2C9 (0.71) KCNH2CYP2C9CCR5
Trifluoroacetic Acid SCHEMBL1749263 0.76 KCNH2 (0.36) KCNH2CYP2C9ERCC1FEN1ERCC4
SCHEMBL1750481 0.75 GAA (0.38) CYP2C9ERCC1FEN1ERCC4
SCHEMBL12529332 0.72 KCNH2 (0.39) KCNH2CYP2C9
SCHEMBL1750834 0.72 KCNH2 (0.64) KCNH2CYP2C9ERCC1FEN1ERCC4
SCHEMBL12529339 0.70 KCNH2 (0.46) KCNH2CYP2C9
SCHEMBL2202249 0.70 ALDH1A1 (0.43) KCNH2CYP2C9ERCC1FEN1ERCC4
SCHEMBL2206742 0.68 ALDH1A1 (0.42) KCNH2CYP2C9ERCC1FEN1ERCC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7968553-B2 e.g. N-(4-fluorobenzyl)-3-hydroxy-4-oxo-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidine-2-carboxamide; viricide in combination with other HIV/AIDS antivirals, immunomodulators, antibiotics or vaccines; AIDS ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI S.P.A. (IT) 2011-06-28 US disclosed
EP-1578748-B1 TETRAHYDRO-4H-PYRIDO[1,2-A]PYRIMIDINES AND RELATED COMPOUNDS USEFUL AS HIV INTEGRASE INHIBITORS ANGELETTI P IST RICHERCHE BIO (IT) 2010-09-15 EP disclosed
US-7414045-B2 Substituted pyrimido[1,2-a]azepines useful as HIV integrase inhibitors ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI S.P.A. (IT) 2008-08-19 US disclosed
US-20080176869-A1 Tetrahydro-4H-pyrido[1,2-a] pyrimidines useful as HIV integrase inhibitors MSD ITALIA S.R.L. (IT) 2008-07-24 US disclosed
US-20060046985-A1 Tetrahydro--4h-pyrido[1,2-a}pyrimidines and related compounds useful as hiv integrase inhibitors MSD ITALIA S.R.L. (IT) 2006-03-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060046985-A1 Tetrahydro--4h-pyrido[1,2-a}pyrimidines and related compounds useful as hiv integrase inhibitors TYMS, TYMP, HPRT1 KCNH2 3284/4885CYP2C9 754/4885DPP4 646/4885
US-20080176869-A1 Tetrahydro-4H-pyrido[1,2-a] pyrimidines useful as HIV integrase inhibitors TYMS, TYMP, DPYD KCNH2 3301/4885CYP2C9 740/4885DPP4 603/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.